All stock lists
Axon Enterprise, Inc. (NASDAQ:AXON)
US · Delayed Price · Currency is USD
Also listed: 0HKE.L, TASRIndustrials · Aerospace & Defense
424.77+4.40 (+1.05%)
Market cap
$34.5B
Health Score
Analyst consensus
Listed since
Jun 7, 2001
Website
Insider Score
––Not scored
AXON Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AXON analyst forecast
AXON analyst consensus
Moderate Buy5 ratings
Buy 4 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AXON 12-month price target
No published price targets in the last 12 months.
Best analysts covering AXON
- Barclays90%success rate · 10 calls
- JP Morgan80%success rate · 5 calls
- Goldman Sachs75%success rate · 4 calls
- Needham67%success rate · 18 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AXON analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-10-20 |
| — | Argus Research | Buy | — | — | Reiterated | 2026-09-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-08-06 |
| — | UBS | Neutral | — | — | Reiterated | 2026-08-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-07-13 |
| — | Needham | Buy | — | — | Reiterated | 2026-07-06 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-06-25 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-08 |
| — | UBS | Neutral | — | — | Reiterated | 2026-05-07 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-07 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-05-07 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-05-07 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-16 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-13 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-04-08 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-04-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-25 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-25 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-02-25 |
| — | UBS | Neutral | — | — | Reiterated | 2026-02-25 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-02-25 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-20 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-12-17 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-11-05 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-11-05 |
| — | UBS | Neutral | — | — | Reiterated | 2025-11-05 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-09-29 |
| — | Needham | Buy | — | — | Reiterated | 2025-09-24 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-08-06 |
| — | Northland Capital Markets | Outperform | — | — | Reiterated | 2025-08-05 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-08-05 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-05 |
| — | UBS | Neutral | — | — | Reiterated | 2025-08-05 |
| — | Craig-Hallum | Buy | — | — | Upgraded | 2025-08-05 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-07-22 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-07-17 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-06-04 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-05-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-05-09 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-08 |
| — | Northland Capital Markets | Outperform | — | — | Reiterated | 2025-05-08 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-23 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-02-27 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-26 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-02-26 |
| — | Craig-Hallum | Hold | — | — | Downgraded | 2025-02-20 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-02-04 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-01-27 |
| — | Baird | Outperform | — | — | Reiterated | 2024-12-06 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2024-12-03 |
| — | Northland Capital Markets | Outperform | — | — | Reiterated | 2024-11-11 |
| — | Baird | Outperform | — | — | Reiterated | 2024-11-08 |
| — | Needham | Buy | — | — | Reiterated | 2024-11-08 |
| — | Baird | Outperform | — | — | Reiterated | 2024-11-04 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-10-31 |
| — | Northland Capital Markets | Outperform | — | — | Reiterated | 2024-08-08 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-08-07 |
AXON earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-24 | 1.60 | 2.15 | $755.6M | $796.7M |
| 2026-05-06 | 1.60 | 1.61 | $780.7M | $807.3M |
| 2026-08-05 | 1.84 | 1.88 | $876.4M | $904.4M |
| 2026-11-05 | 1.90 | 0.00 | $937.8M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.